Audit of 1 year survival for patients receiving chemotherapy for NSCLC - all comers

被引：0
|
作者：
Allison, J. L. E. [1 ]
Lord, H. [2 ]
机构：
[1] NHS Tayside, Med Oncol, Dundee, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, NHS Tayside, Oncol, Dundee DD1 9SY, Scotland
来源：
LUNG CANCER | 2016年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
81
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [41] Survival Determinants in Gefitinib-Sensitive Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Two Sequences of Gefitinib and Chemotherapy
    Lee, Young Joo
    Yun, Tak
    Han, Ji Youn
    Kim, Heung Tae
    Lee, Jin Soo
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S402 - S402
  • [42] Symptom Clusters And Quality Of Life Over 1 Year In Breast Cancer Patients Receiving Adjuvant Chemotherapy
    Berger, Ann M.
    Kumar, Gaurav
    LeVan, Tricia D.
    Meza, Jane L.
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2020, 7 (02) : 134 - 140
  • [43] Resactable NSCLC patients receiving neoadjuvant chemotherapy plus nivolumab-real world data
    Baumgartner, L. V.
    Wohlkoenig, C.
    John, N.
    Maier, A.
    Talakic, E.
    Brcic, L.
    Douschan, P.
    Kneidinger, N.
    Wurm, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S552 - S552
  • [44] Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy
    Shimokawa, Mototsugu
    Haratake, Naoki
    Takada, Kazuki
    Toyokawa, Gouji
    Takamori, Shinkichi
    Mizuki, Fumitaka
    Takenaka, Tomoyoshi
    Hayashi, Toshinobu
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2673 - 2680
  • [45] Overall Survival by IDO1 and PD-L1 Expression in NSCLC Patients Receiving an Immune Checkpoint Inhibitor (ICI)
    Moore, M.
    Hall, R.
    Mcloughlin, E.
    Melson, J.
    Horton, B.
    Mills, A.
    Gentzler, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S738 - S738
  • [46] Venous thromboembolism and all-cause mortality in cancer patients receiving chemotherapy
    Kuderer, N. M.
    Francis, C. W.
    Culakova, E.
    Khorana, A. A.
    Ortel, T.
    Falanga, A.
    Lyman, G. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy
    Davide Tassinari
    Luigi Montanari
    Marco Maltoni
    Michela Ballardini
    Alessandra Piancastelli
    Marco Musi
    Giampiero Porzio
    Vincenzo Minotti
    Augusto Caraceni
    Barbara Poggi
    Anna Stella
    Federica Aielli
    Emanuela Scarpi
    Supportive Care in Cancer, 2008, 16 : 359 - 370
  • [48] Determinants of quality of life and survival in ambulatory oncology patients receiving chemotherapy.
    Power, Derek Gerard
    Daly, Louise
    Bhuachalla, Eadaoin Ni
    Cushen, Samantha
    Mceneaney, Peter
    Dahly, Darren L.
    Ryan, Aoife M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] 3-Year Overall Survival for Patients with Advanced NSCLC Treated with Pembrolizumab
    Hellmann, Matthew D.
    Leighl, Natasha B.
    Hui, Rina
    Carcereny, Enric
    Felip, Enriqueta
    Ahn, Myung-Ju
    Eder, Joseph Paul
    Balmanoukian, Ani S.
    Aggarwal, Charu
    Horn, Leora
    Patnaik, Amita
    Gubens, Matthew A.
    Ramalingam, Suresh S.
    Lubiniecki, Gregory M.
    Zhang, Jin
    Piperdi, Bilal
    Garon, Edward B.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 60 - 61
  • [50] Survival Advantages in Gastric Cancer Patients Receiving Preoperative SOX Regimen Chemotherapy
    Zhang, Qian
    Zhang, Qinghua
    Yan, Hui
    You, Yanjie
    Cao, Juan
    Wang, Wenfan
    Zhao, Dan
    Zhang, Xiaoxu
    Wu, Jing
    Chen, Zhiqiang
    Yang, Wenjun
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2023, 38 (02) : 81 - 88
12345